Evusheld (tixagevimab And Cilgavimab For Injection) - Risk Of Prophylaxis Or Treatment Failure Due To Antiviral Resistance
EVUSHELD Recall Summary Evusheld, an injectable medication used to prevent or treat COVID-19, is being recalled in Canada due to the emergence of virus variants that may resist the drug's effectiveness. The recall affects all batches of this product distributed across Canada. Health Canada issued this recall based on new safety information showing the medication may no longer work as intended against current virus strains.
- Product
- EVUSHELD (tixagevimab and cilgavimab for injection)
- Reason
- New safety information - Product safety - COVID
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2022-10-26
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/095f357d-60dd-47a7-9166-7540c40cbc81